Search Results - I. G. Bakulin

Refine Results
  1. 1

    Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B by I. G. Bakulin

    Published 2009-02-01

    The aim of review. To estimate safety and efficacy of prescription of nucleoside analogues the patient with liver cirrhosis in an outcome of chronic hepatitis B.Original positions of the report. Rates of progression of persistent HBV infection to liver cirrhosis stage depend on several factors – spe...

    Full description

    Get full text
    Article
  2. 2

    Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases by O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin

    Published 2018-09-01

    The issues of prevention of thromboembolic complications (TE) in the management of patients with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention of...

    Full description

    Get full text
    Article
  3. 3

    MATHEMATICAL MODELS PREDICTING LEUKOPENIA AND NEUTROPENIA IN PATIENTS WITH CHRONIC HEPATITIS C IN THE BACKGROUND INTERFERONCONTAINING SCHEMES by I. G. Bakulin, N. Kh. Dianova, Yu. G. Sandler, M. Yu. Prostov

    Published 2016-10-01

    Currently in the Russian Federation or chronic hepatitis C (CHC) are still relevant Interferon-based regimens. The purpose of this study is to investigate the influence of baseline characteristics and prognosis of the patient HCV genotype 1 for the development  of leukopenia (LP) and neutropenia  (N...

    Full description

    Get full text
    Article
  4. 4

    COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH by I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii

    Published 2018-03-01

    In connection with the increase in the life expectancy of modern people, in recent years questions of comorbid conditions have become of great interest among clinicians. Comorbidity, which increases with the age of patients, may reduce their adherence to treatment, including because of the use of mu...

    Full description

    Get full text
    Article
  5. 5

    EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-C... by K. V. Zhdanov, I. G. Bakulin, D. A. Gusev, V. G. Morozov, K. V. Kozlov

    Published 2018-01-01

    Aim. Study of efficacy and safety of ribavirin in combination to pegylated interferon α-2a (PegIFN- α-2a) within combined mode of treatment of patients with chronic hepatitis C (CHC) including patients with compensated cirrhosis and and HIV coinfection were conducted. Material and methods. Two open...

    Full description

    Get full text
    Article
  6. 6

    Alcohol abuse in gastroenterological patients by M. V. Mayevskaya, I. G. Bakulin, A. A. Chirkov, Ye. O. Lyusina, V. D. Lun’Kov

    Published 2018-08-01

    Aim of investigation. To estimate the role of alcohol abuse in gastroenterological patients. Material and methods. Overall 345 patients with various gastrointestinal diseases were enrolled in the study. Of all patients 162 (46,9%) were males, 183 (53,1%) were females, mean age was 43,18±13,04 years....

    Full description

    Get full text
    Article
  7. 7

    Primary angiosarcoma under the guise of constrictive pericarditis: a case report by O. Yu. Chizhova, I. G. Bakulin, T. E. Skvortsova, D. S. Zueva, S. A. Boldueva, O. M. Zhorina, D. A. Yakovlev

    Published 2023-08-01

    Primary cardiac tumors are histologically heterogeneous and grow from the heart tissues. Their diagnosis is difficult due to the absence of pathognomonic signs, as well as the possibility of a long asymptomatic course. The authors present a case of late diagnosis of heart tumor in a young man, occur...

    Full description

    Get full text
    Article
  8. 8

    Key Scientific Achievements in Gastroenterology in 2024: Meeting of the Internal Medicine Sciences’ Council of the Department of Medical Sciences of the Russian Academy of Sciences... by O. M. Drapkina, I. V. Maev, D. S. Bordin, I. G. Bakulin, E. V. Garbuzova, A. I. Ershova, M. A. Livzan

    Published 2025-05-01

    19.12.2024 состоялось очередное заседание Совета по терапевтическим наукам Секции клинической медицины РАН, посвященное ключевым научным достижениям гастроэнтерологии в 2024 г. В ходе заседания обсуждались актуальные вопросы гастроэнтерологической практики, включая проблемы профилактики рака желудка...

    Full description

    Get full text
    Article
  9. 9

    Pneumomediastinum: a New Look at an Old Problem in a COVID-19 Pandemic by O. Y. Chizhova, I. A. Ruslyakova, I. G. Bakulin, N. A. Prokofieva, A. G. Sushilova, G. M. Glazunova, K. M. Lebedinsky

    Published 2022-08-01

    The aim of the study was to identify the risk factors of spontaneous pneumomediastinum and to determine its management strategy in patients with the novel coronavirus infection.Material and methods. Eighteen patients with spontaneous pneumomediastinum (SPM) hospitalized in the Center for Novel Coron...

    Full description

    Get full text
    Article
  10. 10

    Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement) by M. Yu. Nadinskaia, M. V. Maevskaya, I. G. Bakulin, E. N. Bessonova, A. O. Bueverov, M. S. Zharkova, S. V. Okovityi, A. S. Ostrovskaya, K. A. Gulyaeva, V. T. Ivashkin

    Published 2024-03-01

    Introduction. In cirrhotic patients, hyperammonemia develops due to impaired ammonia detoxification and portosystemic blood shunting and is most commonly associated with hepatic encephalopathy and sarcopenia. Currently, there are questions regarding the diagnosis of hyperammonemia and the effect of...

    Full description

    Get full text
    Article
  11. 11

    MALT lymphoma and erosive and ulcerative lesions of the stomach: modern diagnostic approaches and own clinical observation by I. G. Bakulin, N. V. Bakulinа, S. L. Vorobyov, E. A. Popova, O. A. Malikhova, P. A. Zeynalova, T. A. Ilchishina, V. V. Lozovaya, F. M. Abbasbeyli

    Published 2019-10-01

    Due to the pronounced polymorphism of stomach MALT-lymphoma endoscopic manifestations, often mimicking inflammatory changes of various etiologies, difficulties arise in the timely diagnosis of this disease. The alertness of the endoscopist and the use of integrated approaches to endoscopic diagnosis...

    Full description

    Get full text
    Article
  12. 12
  13. 13

    The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program by V. T. Ivashkin, M. V. Mayevskaya, D. T. Abdurakhmanov, I. G. Bakulin, N. I. Geyvandova, M. L. Zubkin, S. N. Kizhlo, A. V. Kuznetsova, I. B. Latysheva, N. A. Mamonova, V. G. Morozov, O. I. Sagalova, Ye. V. Esaulenko, Ye. O. Lyusina

    Published 2018-08-01

    Introduction. The options of antiviral therapy (AVT) in the stages of severe liver fibrosis and cirrhosis (LC) as well as in the patients with comorbidities for the long time were limited to the standard therapy by pegilated interferon (peg-IFN) in combination to ribavirin (RBV). Before official reg...

    Full description

    Get full text
    Article
  14. 14

    COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patient... by V. T. Ivashkin, R. A. Abdulkhakov, I. G. Bakulin, S. V. Zaitsev, V. I. Luchina, S. N. Mekhtiyev, S. G. Peshekhonov, E. A. Poluektova, T. I. Semenova, S. N. Serikova, G. N. Tarasova, E. A. Trush, Y. P. Uspenskiy, I. B. Khlynov, V. V. Tsukanov, N. P. Chernus

    Published 2023-12-01

    Aim: to study the effectiveness and safety of using the drug Kolofort® in outpatients with irritable bowel syndrome (IBS) after a new coronavirus infection.Materials and methods. An observational non-interventional program was conducted in patients with exacerbation of IBS symptoms after a new coron...

    Full description

    Get full text
    Article
  15. 15

    Резолюция Экспертного совета «Диагностика и лечение больных со сладжем в желчном пузыре» by V. T. Ivashkin, Alexey V. Okhlobystin, Dmitry S. Bordin, M. F. Osipenko, E. Ya. Seleznyova, Yu. O. Shulpekova, S. R. Abdulkhakov, O. P. Alexseyeva, I. G. Bakulin, L. G. Vologjhanina, V. B. Grinevich, N. V. Bakulina, T. A. Kolesova, N. V. Korochanskaya, I. V. Putintseva, A. S. Sarsenbayeva, N. S. Yazenok

    Published 2018-08-01

    Aim of publication. To present the data of Advisory council which took place on August 19, 2016 in Poland (Krakow) with the participation of Adamed Russia company. Summary. Advisory council activity provided the algorithm of diagnosis and treatment of biliary sludge. At detection of gallbladder slud...

    Full description

    Get full text
    Article
  16. 16

    Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study by D. T. Abrurakhmanov, V. G. Morozov, I. G. Nikitin, P. O. Bogomolov, N. I. Geyvandova, Ye. N. Bessonova, I. G. Bakulin, V. A. Isakov, K. V. Zhdanov, M. V. Mayevskaya, Ye. A. Nurmukhametova, E. Z. Burnevich, Ye. V. Chesnokov, V. D. Pasechnikov, A. Hill, I. Lonjon-Domanec, S. N. Kizhlo

    Published 2014-07-01

    Aim of investigation. HEP3002 is the international early access program of efficacy and safety estimation of telaprevir in combination to peginterferon alpha and ribavirin for patients with severe fibrosis or liver cirrhosis caused by hepatitis C virus (HCV) genotype 1. Efficacy and safety of this t...

    Full description

    Get full text
    Article
  17. 17

    Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized plac... by V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

    Published 2018-08-01

    Aim of investigation. To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and methods. Original study included overall 180 patients w...

    Full description

    Get full text
    Article
  18. 18

    Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlle... by I. G. Bakulin, N. A. Bokhan, P. O. Bogomolov, N. I. Geyvandova, M. V. Matsiyevich, M. A. Vinnikova, V. G. Morozov, O. M. Khromtsova, G. S. Soldatova, O. Yu. Shiryayev, R. D. Ilyuk, K. V. Rybakova, A. G. Katkovskaya, S. V. Teplykh, A. A. Bagretsova, M. V. Krasnova, Ye. V. Alekseyeva, A. V. Anipchenko, Ye. V. Baskakov

    Published 2018-08-01

    Material and methods. The original study included overall 120 patients with ALD, who were randomized in two identical groups. The patients of the main group (group A) received 2 courses of therapy: the first - Phosphogliv 5 mg/day as intravenous bolus injection for 2 wks, followed by the oral intake...

    Full description

    Get full text
    Article
  19. 19
  20. 20

    H. pylori-Associated Gastritis, Gastritis after H. pylori Eradication and H. pylori-Negative Gastritis: Algorithm of Diagnosis and Treatment (Literature Review and Resolution of... by V. T. Ivashkin, I. V. Maev, T. L. Lapina, Yu. A. Kucheryavyy, S. R. Abdulkhakov, O. P. Alekseeva, S. A. Alekseenko, D. N. Andreev, I. G. Bakulin, N. V. Bakulina, D. S. Bordin, Z. M. Galeeva, N. N. Dekhnich, N. V. Korochanskaya, R. O. Kuvaev, M. A. Livzan, M. F. Osipenko, S. S. Pirogov, V. I. Simanenkov, O. A. Storonova, A. S. Tertychnyy, A. S. Trukhmanov, Yu. P. Uspenskiy, I. B. Khlynov, V. V. Tsukanov

    Published 2024-08-01

    Aim: to provide the basic points of the Expert Panel of the Russian Gastroenterological Association with discussion of measures to improve diagnostics, treatment and management of chronic gastritis patients.Key points. In the Russian Federation in 2021 more than 30 million patients diagnosed with “G...

    Full description

    Get full text
    Article